Your source for expert insights into the future of healthcare. Factide delivers in-depth coverage of biotechnology, medical engineering, and the AI-driven innovations transforming global health outcomes with precision and speed.
Climate cycles create synchronized global water extremes, reshaping food security and public health risks. Dry conditions now dominate, with implications for disease outbreaks and healthcare systems.
Engineered bacteria produce tagatose, a rare sugar with 60% fewer calories than sucrose. FDA-approved and sweet, it offers a healthier alternative. Discover the breakthrough method here.
Explore the evolving relationship between work stress and leisure in modern health trends. This article contextualizes general observations without overinterpreting limited source material.
A home-based tDCS device showed a 64% response rate in treating depression, but experts caution more research is needed to confirm long-term safety and efficacy.
Anavex seeks FDA re-evaluation of its Alzheimer’s drug after revised trial data shows potential cognitive benefits.
New method using MEG and beta frequency analysis may predict Alzheimer’s up to 2.5 years before symptoms appear, according to a study published in *Imaging Neuroscience*.
Formula E champion Lucas di Grassi examines cognitive aging in elite motorsport, balancing high-performance demands with longevity strategies.
CKM Syndrome affects 90% of U.S. adults but is largely unknown. The American Heart Association is addressing awareness gaps and launching new guidelines.
A CRISPR-based study identifies 331 genes critical for brain cell development and links PEDS1 mutations to a neurodevelopmental disorder. The open-access database could accelerate research.
New coffee compounds in roasted beans show stronger α-glucosidase inhibition than acarbose in lab tests, raising potential for diabetes management.
NRG Therapeutics begins Phase 1 trials for NRG5051, targeting mitochondrial dysfunction in ALS and Parkinson’s. The drug aims to address root causes of neurodegeneration.
The Longevity Show 2026 unites science, finance, and health systems to advance equitable longevity solutions for humans and pets.
